Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Albemarle Corporation

Statement of Changes in Beneficial Ownership

Initial Statement of Beneficial Ownership

Insider	Title	Transaction Type	Shares Traded	% of Shares Traded	% Chg. in Shares	End of Filing Shares	Price	Transaction Value	Filing Date	Transaction Date
Glenda J. Minor	CFO & Senior Vice President, Independent Director, Supervisory Board Member Show All	Other Acquisition (Buy)	1.75K	0.001489%	42.62%	5.86K	—	—	03 Jul 2024	01 Jul 2024 - 01 Jul 2024
Ralf H. Cramer	Member of Executive Board, Independent Director Show All	Sale to Issuer (Sale)	-259	-0.00022%	-7.42%	3.23K	$97.41 - $97.41	-$25.23K	03 Jul 2024	01 Jul 2024 - 01 Jul 2024
Ralf H. Cramer	Member of Executive Board, Independent Director Show All	Other Acquisition (Buy)	1.76K	0.001497%	119.57%	3.23K	—	—	03 Jul 2024	01 Jul 2024 - 01 Jul 2024
Mary Lauren Brlas	Executive Vice President and Chief Financial Officer, Independent Director, Director, Non-Executive Director Show All	Other Acquisition (Buy)	1.76K	0.001497%	21%	10.14K	—	—	03 Jul 2024	01 Jul 2024 - 01 Jul 2024
James J. O’Brien	President, Director, Chairman of Ashland Inc., CEO of Ashland Inc. and Director of Ashland Inc, Independent Director, Lead Independent Director Show All	Other Acquisition (Buy)	1.76K	0.001497%	49.4%	5.32K	—	—	03 Jul 2024	01 Jul 2024 - 01 Jul 2024
Diarmuid B. O'Connell
Diarmuid B. O'Connell
Alejandro Daniel Wolff
Alejandro Daniel Wolff
Gerald A. Steiner
Dean L. Seavers
Dean L. Seavers
Holly A. Van Deursen
Mark Mummert
Mark Mummert
Mark Mummert
Mark Mummert
Mark Mummert
John Clarence Barichivich
Eric W. Norris
Eric W. Norris
John Clarence Barichivich
John Clarence Barichivich
Netha N. Johnson
Netha N. Johnson
Jacobus Gerhardus Fourie
Jacobus Gerhardus Fourie
Kristin Buchholz Coleman
Kristin Buchholz Coleman
John Clarence Barichivich